Wandall Group

We investigate how glycans impinge on cells during development, inflammation, and cancer growth, and how to exploit this for early detection and treatment of disease, and we explore and map glycogenes with new enzymatic technologies to turn genes on and off and identify new causes of disease.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

hans wandallGroup Leader

Hans H. Wandall
Professor, MD, PhD
Deputy head of department
hhw@sund.ku.dk

(+45) 23 84 01 56 / (+45) 35 33 55 53
CV, publications, etc

Glycomics Program
Copenhagen Center for Glycomics